Introducing Proactiv's NEW Post Blemish 10% Vitamin C Serum™ Helps Even and Brighten Acne-Prone Skin [Yahoo! Finance]
Taro Pharmaceutical Industries Ltd. Ordinary Shares (TARO)
Last taro pharmaceutical industries ltd. ordinary shares earnings: 2/3 05:21 pm
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=114698&p=irol-irhome
Company Research
Source: Yahoo! Finance
Routine, announced the launch of its latest innovation: the Post Blemish 10% Vitamin C Serum™. Created specifically for acne-prone skin, this unique serum is designed to visibly even and smooth the appearance of skin, helping users achieve a radiant post blemish complexion. Crafted with a potent blend of ingredients, including 10% vitamin C (3-O-ethyl ascorbic acid), licorice root, centella asiatica, and hyaluronic acid, this post blemish serum targets post inflammatory hyperpigmentation while safeguarding against environmental stressors that can contribute to skin darkening. This fragrance free, lightweight formula is fast absorbing, creating an invisible shield that restores the skin's natural radiance and brightness. "Our mission at Proactiv is to help people feel confident about their skin by providing effective skincare solutions," says Samantha Boulukos , Head of Business at Alchemee. "Proactiv's new serum helps fade the appearance of hyperpigmentation with skin-loving ingre
Show less
Read more
Impact Snapshot
Event Time:
TARO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TARO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TARO alerts
High impacting Taro Pharmaceutical Industries Ltd. Ordinary Shares news events
Weekly update
A roundup of the hottest topics
TARO
News
- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.MarketBeat
- Taro Provides Results for Year Ended March 31, 2024 [Yahoo! Finance]Yahoo! Finance
- Taro Provides Results for Year Ended March 31, 2024Business Wire
- Shareholder Alert: Ademi LLP investigates whether Taro Pharmaceutical Industries Limited has obtained a Fair Price for its Public Shareholders in its transaction with its majority shareholder, Sun Pharmaceutical Industries Limited.PR Newswire
- Taro to Release Full Year Results on May 20, 2024Business Wire
TARO
Earnings
- 5/20/24 - Beat
TARO
Sec Filings
- 5/21/24 - Form 6-K
- 5/14/24 - Form SC
- 5/8/24 - Form SC
- TARO's page on the SEC website